# Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-19 23:29 UTC · Category: Business · Sources: 2 · Current Velocity: 0.71

## Key People, Organizations & Locations
Merck, Silence, KGaA

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Morningstar | Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders? | 2026-10-19 12:57 | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxObTlhUC1HaWI0UVFxMUJDSHFNUFk1U01TTHpZV19ERjVGY2czRjQ5LXlSay0zMkF4TVlYaEI4bXpNcHFYSkdFdXl1b1BNSlEyeXo5VkRWNFZLUXFzd0Z1WENCNW9KdS1yUjZqTTdudzlmeVBwUHFhcVJQZUxEa0tHSVJYZUkzNzBFX2tsXzRQTHFfSVlxWXlxLWhfdFRTSWlQaEwxYnVsZ2w2SnBXNEhNM19RempRb2dWbThXTzZjRHQzQWN3?oc=5) |
| FirstWord Pharma | Merck KGaA doubles down on rare disease buildout with $1.3B Silence buy | 2026-10-19 12:57 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE1RY1VhWTJrb2ZXTXdEbTFqZFp2eXNac1NKSVh6S0RoZmtMaWNGczZjczNLYlFDT2dFN0tvSG5FZF9ZeVZjMlZZTWFsTW5NX2ZDLWV3?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-19/merck-kgaa-buys-silence-in-1-3b-deal-after-sirna-drug-s-phase-2-blood-cancer-win*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*